© 1991 Oxford University Press
research-article |
Tumors of the Skin in the HRA/Skh Mouse after Treatment with 8-Methoxypsoralen and UVA Radiation



*National Institute of Environmental Health Sciences Research Triangle Park, North Carolina 27709
Temple University Health Sciences Center Philadelphia, Pennsylvania 19122
Experimental Pathology Laboratories Research Triangle Park, North Carolina 27709
PATHCO, Inc. Gaithersburg, Maryland 20879
Received March 2, 1990; accepted September 11, 1990
8-Methoxypsoralen (8-MOP) with and without UVA radiation was administered to HRA/Skh mice (36 animals per treatment group) three times a week in the feed for a total dose of 980 mg/kg/week for 52 weeks. Most of the animals at the top dose of 8-MOP with UVA radiation had developed skin toxicity and/or skin tumors by 52 weeks. The skin lesions seen after treatment with 8-MOP and UVA radiation were characterized as squamous cell hyperplasia, squamous cell papilloma, and squamous cell carcinoma and are similar to what has been reported in humans after exposure to 8-MOP and UVA. Squamous cell hyperplasia and acute inflammation of the cornea were also seen in some of the treated female mice. Oral administration of 8-MOP and UVA did not result in a carcinogenic response to other organ systems. There were no increases in skin neoplasms after 8-MOP or UVA radiation alone. 8-MOP given in combination with UVA was carcinogenic to the skin of mice at dose levels similar to those used to treat psoriasis in humans.